Early Oxygen Treatment Measurements Can Predict COVID-19 Mortality: A Preliminary Study
暂无分享,去创建一个
E. Shmueli | D. Yamin | T. Patalon | S. Gazit | A. Peretz | B. Nahir | Yosi Levi | Tomer Brandes
[1] A. Munitz,et al. BNT162b2 vaccination effectively prevents the rapid rise of SARS-CoV-2 variant B.1.1.7 in high-risk populations in Israel , 2021, Cell Reports Medicine.
[2] A. Munitz,et al. The rise of SARS-CoV-2 variant B.1.1.7 in Israel intensifies the role of surveillance and vaccination in elderly , 2021, medRxiv.
[3] G. Wainrib,et al. Integrating deep learning CT-scan model, biological and clinical variables to predict severity of COVID-19 patients , 2021, Nature Communications.
[4] R. Glover,et al. Vaccinating against covid-19 in people who report allergies , 2021, BMJ.
[5] G. Leung,et al. Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020 , 2021, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[6] P. Dormitzer,et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine , 2020, The New England journal of medicine.
[7] J. López-Barneo,et al. Is Carotid Body Infection Responsible for Silent Hypoxemia in COVID-19 Patients? , 2020, Function.
[8] N. Schmit,et al. Adapting hospital capacity to meet changing demands during the COVID-19 pandemic , 2020, BMC Medicine.
[9] Ding Ma,et al. Machine learning based early warning system enables accurate mortality risk prediction for COVID-19 , 2020, Nature Communications.
[10] Urvish K. Patel,et al. Biomarkers and outcomes of COVID-19 hospitalisations: systematic review and meta-analysis , 2020, BMJ Evidence-Based Medicine.
[11] N. Shenoy,et al. Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting? , 2020, BMC Medicine.
[12] Luoping Zhang,et al. Biomarkers of COVID-19 and technologies to combat SARS-CoV-2 , 2020, Advances in Biomarker Sciences and Technology.
[13] Yair Neuman,et al. Utilization of machine-learning models to accurately predict the risk for critical COVID-19 , 2020, Internal and Emergency Medicine.
[14] Liang Chen,et al. Understand variability of COVID-19 through population and tissue variations in expression of SARS-CoV-2 host genes , 2020, Informatics in Medicine Unlocked.
[15] Xuguang Li,et al. The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity , 2020, Cell.
[16] Zhe Luo,et al. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study , 2020, Journal of Intensive Care.
[17] Ali Kashif Bashir,et al. COVID-19 Patient Health Prediction Using Boosted Random Forest Algorithm , 2020, Frontiers in Public Health.
[18] B. Grenfell,et al. Disease and healthcare burden of COVID-19 in the United States , 2020, Nature Medicine.
[19] Paari Dominic,et al. Prognostic value of Cardiac Biomarkers in COVID-19 Infection: A Meta-analysis , 2020, Research square.
[20] C. Ruini,et al. Biomarkers associated with COVID-19 disease progression , 2020, Critical reviews in clinical laboratory sciences.
[21] L. Mombaerts,et al. An interpretable mortality prediction model for COVID-19 patients , 2020, Nature Machine Intelligence.
[22] Marcus J Schultz,et al. Respiratory Support in COVID-19 Patients, with a Focus on Resource-Limited Settings , 2020, The American journal of tropical medicine and hygiene.
[23] Jiang Xie,et al. Association Between Hypoxemia and Mortality in Patients With COVID-19 , 2020, Mayo Clinic Proceedings.
[24] Eduardo Missoni,et al. The Italian health system and the COVID-19 challenge , 2020, The Lancet Public Health.
[25] Megan L Ranney,et al. Critical Supply Shortages - The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic. , 2020, The New England journal of medicine.
[26] Yunpeng Ji,et al. Potential association between COVID-19 mortality and health-care resource availability , 2020, The Lancet Global Health.
[27] L. Gostin,et al. The Novel Coronavirus Originating in Wuhan, China: Challenges for Global Health Governance. , 2020, JAMA.
[28] B. Rochwerg,et al. High-flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: author's reply , 2019, Intensive Care Medicine.
[29] L. Brochard,et al. High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis , 2019, Intensive Care Medicine.
[30] Jeffrey K Aronson,et al. Biomarkers—A General Review , 2017, Current protocols in pharmacology.
[31] World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance , 2020 .
[32] F. J. Pilar,et al. High-Flow Nasal Cannula Oxygen in Acute Respiratory Post-extubation Failure in Pediatric Patients: Key Practical Topics and Clinical Implications , 2016 .
[33] A. Esquinas. Noninvasive Mechanical Ventilation and Difficult Weaning in Critical Care , 2016 .